ReviewEndocrinology2025

Epigenomic Modulators and Thyroid Hormone Receptor β Agonists: A New Paradigm for Tumor Suppression in Thyroid Cancer.

John L Rustad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.